Search
for

    GlossaryClascoterone (Breezula)

    topical medication that blocks androgen receptors to treat hair loss

    Clascoterone is a topical medication used to treat acne and androgenetic alopecia (a common form of hair loss). It works by blocking androgen receptors in the skin, which helps reduce the effects of hormones like testosterone that can contribute to these conditions.

    Related Terms

    Learn

    2 / 2 results

      learn Clascoterone

      a novel topical treatment that inhibits DHT on androgen receptors

    Research

    5 / 12 results

    Community Join

    5 / 248 results

      community Breezula phase 3 results where are youuuu👀

      in Satire  17 upvotes 6 days ago
      Breezula's phase 3 results are expected soon, but its release is likely delayed until 2027 or 2028. The discussion highlights the need for more hair growth stimulants like AMP-303 and PP-405, as current treatments like Dutasteride effectively stop hair loss but don't regrow hair.

      community What the hell happened to Breezula?

      in Research/Science  14 upvotes 1 month ago
      Breezula (clascoterone) Phase 3 hair loss trial results are delayed, with no official updates yet. The acne version is approved, but hair loss results are still pending.

      community Whatever happened to breezula?

      in Finasteride/Dutasteride  17 upvotes 2 months ago
      Breezula, a potential hair loss treatment, is still in trials with no recent updates on its release, while its acne version, Winlevi, is available but expensive. Users discuss the high cost of hair loss treatments and alternatives like Minoxidil and topical Finasteride.